All News #Library
Biotech
Valo Secures €19M Funding, Expands Clinical Trials
10 Mar 2025 //
GLOBENEWSWIRE
ValoTx, Texcell ink collaboration to evaluate immune responses to PeptiCRAd-1
15 Jun 2023 //
PHARMABIZ
Valo Announces First Patient Dosed with PeptiCRAd-1 - Innovative Immuno-oncology
23 May 2023 //
GLOBENEWSWIRE
Valo Announces European Patents Granted for PeptiCRAd-1 in Immuno-Oncology
16 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support